期刊文献+

停用免疫抑制药对肾移植肺部感染患者人肾长期存活的影响 被引量:9

Transient stopping immunosuppressive agents during the post-transplant pulmonary infection does not affect the long-term outcome of renal transplantation
在线阅读 下载PDF
导出
摘要 目的:探讨停用免疫抑制药对肾移植受体及移植肾长期生存的影响。方法:选取2005年12月至2014年8月在中南大学湘雅医院器官移植中心接受肾移植手术后出现肺部感染的患者共104例,其中50例患者在肺部感染治疗期间停用免疫抑制药,作为停药组,余54例作为对照组。比较两组间受者以及肾5年累积生存率及感染期间生化指标的变化情况。结果:停药组的受体5年累积生存率明显低于对照组[(69.8±7.0)%对比(94.2±3.2)%,P=0.001],但移植肾生存率两组间差异无统计学意义[(81.7±6.6)%对比(90.9±4.3)%,P=0.113]。肺部感染康复后,停药组受体的长期生存率与对照组相比差异无统计学意义(P=0.979)。结论:肺部感染严重危害肾移植受体的生存;停用免疫抑制药对于肾移植术后严重肺部感染患者而言并不影响患者和移植肾的长期存活。 Objective: To determine the eff ect of transient withdrawal of immunosuppressive agents during the treatment of pulmonary infection on long-term survival of patients and graft s. Methods: A total of 104 patients with post-transplant pulmonary infection were enrolled in this study. Th ese patients received renal transplantation in Center for Organ Transplantation, Xiangya Hospital, Central South University, during December 2005 and August 2014. Among them, 50 patients stopped immunosuppressive agents during the treatment of infection. These patients served as stopping drug(SD) group, whereas the remaining patients who served as a control group did not stop immunosuppressive drugs. Th e five-year cumulative patient survival, graft survival, and laboratory results were compared between the 2 groups. Results: The five-year cumulative patient survival rates in the SD group were significantly lower than those in the control group [(69.8±7.0)% vs(94.2±3.2)%, P=0.001]. There was no significant difference in the allograft survival rates between the 2 groups [(81.7±6.6)% vs(90.9±4.3)%, P=0.113]. In patients who survived from pulmonary infection, there was no significant difference in long-term survival rates between the 2 groups(P=0.979). Conclusion: Pulmonary infection impacts allograft survival after patients underwent renal transplantation. Transient stopping immunosuppressive agents during the treatment of infection is a safe and necessary treatment strategy for patients with serious post-transplant pulmonary infection.
出处 《中南大学学报(医学版)》 CAS CSCD 北大核心 2015年第4期380-386,共7页 Journal of Central South University :Medical Science
基金 国家自然科学基金青年基金(30801386) 湖南省科技计划重点项目(2013FJ2007)~~
关键词 肾移植 肺部感染 免疫抑制药 renal transplantation pulmonary infection immunosuppressive agents
  • 相关文献

参考文献8

二级参考文献49

  • 1张波,王蓉美,樊再雯,刘颖,纪树国.肾移植术后并发急性呼吸窘迫综合征的救治[J].世界急危重病医学杂志,2004,1(6):415-419. 被引量:5
  • 2闵志廉,朱有华,何长民,贺宗理,孟钢,王卓伟,齐隽,王立明,郑军华,徐丹枫,王亚伟,任吉忠,周梅生,余加仁.尸体肾移植1011例次的临床报告[J].第二军医大学学报,1994,15(5):401-406. 被引量:7
  • 3刘全达,周宁新,史宪杰,段云鹏,段伟东,王刚.肝脏移植术后卡氏肺孢子虫肺炎的诊治[J].中华医院感染学杂志,2005,15(5):530-532. 被引量:9
  • 4周梅生,朱有华,张佩芳,王立明,王亚伟.肾移植患者免疫抑制剂调整与预防呼吸道感染的关系[J].中华器官移植杂志,2005,26(10):598-600. 被引量:18
  • 5赵永斌,朱云松,胡卫列,聂海波,陈昊.肾移植术后早期死亡原因分析[J].临床泌尿外科杂志,2006,21(3):210-212. 被引量:3
  • 6EBPG Expert Group on Renal Transplantation. European best practice guidelines for renal transplantation. Section Ⅳ: Longterm management of the transplant recipient. Ⅳ. 7.1 Late infections. Pneumocystis carinii pneumonia[J]. Nephrol Dial Transplant ,2002,17(Suppl 4) :36 39.
  • 7Rubin R. Infection in the organ transplant recipient//Rubin RH, Young LS. Clinical approach to infection in the compromised host. 4th ed. New York: Kluwer Academic/ Plenum Piblishers, 2002 : 573-679.
  • 8Rubin RH, Wolfson JS, Cosimi AB, et al. Infection in the renal transplant recipient. Am J Med, 1981, 70(2) :41)5-411.
  • 9Fishman JA, Rubin RH. Infection in organ-transplant recipients. N Engl J Med, 1998, 338(24) : 1741-1751.
  • 10Rubin RH. Infectious disease complications of renal transplantion. Kidney Int, 1993, 44(10):221-236.

共引文献49

同被引文献62

引证文献9

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部